Publications by authors named "Scott Wadsworth"

19Publications

Inhibition of p38-MAPK alters SRC coactivation and estrogen receptor phosphorylation.

Cancer Biol Ther 2012 Sep 24;13(11):1026-33. Epub 2012 Jul 24.

Department Medicine, Section of Hematology and Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA.

View Article and Find Full Text PDF
September 2012

Osteogenic activity of locally applied small molecule drugs in a rat femur defect model.

J Biomed Biotechnol 2010 16;2010:597641. Epub 2010 Jun 16.

Department of Biochemistry & Molecular Biology, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ 07103, USA.

View Article and Find Full Text PDF
October 2010

Reducing post-surgical adhesions utilizing a drug-enhanced device: sodium carboxymethylcellulose aqueous gel/poly(p-dioxanone) and Tranilast.

Biomed Mater 2009 Feb 4;4(1):015001. Epub 2008 Nov 4.

Center for Biomaterials and Advanced Technologies, Medical Devices Group, A Division of Ethicon, A Johnson & Johnson Company, Rt 22W, Somerville, NJ 08876, USA.

View Article and Find Full Text PDF
February 2009

Organochlorine-mediated potentiation of the general coactivator p300 through p38 mitogen-activated protein kinase.

Carcinogenesis 2009 Jan 12;30(1):106-13. Epub 2008 Sep 12.

Department of Pharmacology, Tulane University Health Science Center, New Orleans, LA 70112, USA.

View Article and Find Full Text PDF
January 2009

Tranilast: a pharmaceutical candidate for reduction of adhesions using a novel approach.

Semin Reprod Med 2008 Jul;26(4):341-8

Johnson & Johnson Pharmaceutical Research & Development, LLC, Raritan, New Jersey, USA.

View Article and Find Full Text PDF
July 2008

Drugs designed to inhibit human p38 mitogen-activated protein kinase activation treat Toxoplasma gondii and Encephalitozoon cuniculi infection.

Antimicrob Agents Chemother 2007 Dec 8;51(12):4324-8. Epub 2007 Oct 8.

Department of Medicine (Hematology and Medical Oncology), Tulane University School of Medicine, 1430 Tulane Avenue SL-78, New Orleans, Louisiana 70112, USA.

View Article and Find Full Text PDF
December 2007

Reduction of post-surgical adhesion formation with tranilast.

J Surg Res 2007 Aug 8;141(2):153-61. Epub 2007 Jun 8.

Center for Biomaterials & Advanced Technologies, Medical Devices Group, A division of Ethicon, A Johnson & Johnson Company, Somerville, New Jersey, USA.

View Article and Find Full Text PDF
August 2007

A multiplexed proteomics approach to differentiate neurite outgrowth patterns.

J Neurosci Methods 2006 Nov 23;158(1):22-9. Epub 2006 Jun 23.

Center for Advanced Proteomics Research and Department of Biochemistry and Molecular Biology, UMDNJ-New Jersey Medical School, MSB E-609, Newark, NJ 07103, USA.

View Article and Find Full Text PDF
November 2006

HIV-1 Nef-induced FasL induction and bystander killing requires p38 MAPK activation.

Blood 2005 Sep 31;106(6):2059-68. Epub 2005 May 31.

University of Pennsylvania School of Medicine, Department of Pathology & Laboratory Medicine 422 Curie Blvd, Philadelphia, PA 19104, USA.

View Article and Find Full Text PDF
September 2005

A novel role for the immunophilin FKBP52 in copper transport.

J Biol Chem 2004 Jul 7;279(27):27845-8. Epub 2004 May 7.

Department of Biochemistry and Molecular Biology, University of Medicine and Dentistry of New Jersey-New Jersey Medical School, 185 South Orange Avenue, Newark, NJ 07103, USA.

View Article and Find Full Text PDF
July 2004

Suppression of HIV-1 viral replication and cellular pathogenesis by a novel p38/JNK kinase inhibitor.

AIDS 2004 Mar;18(5):739-48

Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.

View Article and Find Full Text PDF
March 2004

Imidazopyrimidines, potent inhibitors of p38 MAP kinase.

Bioorg Med Chem Lett 2003 Feb;13(3):347-50

Drug Discovery, Johnson & Johnson Pharmaceutical Research and Development, L.L.C., 1000 Route 202, Raritan, NJ 08869, USA.

View Article and Find Full Text PDF
February 2003

Opposing roles of serine/threonine kinases MEKK1 and LOK in regulating the CD28 responsive element in T-cells.

Biochem J 2002 Apr;363(Pt 1):175-82

R. W. Johnson Pharmaceutical Research Institute, Drug Discovery Research, Raritan, NJ 08869, USA.

View Article and Find Full Text PDF
April 2002